Ranevetmab
Ranevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain.
For research use only. We do not sell to patients.
- CAS No.: 1632282-27-9
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Caninized IgG1 kappa
Canlupfam
|
NGF |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Dogs with degenerative joint disease (DJD) pain[2]
-
Dosage:200 μg/kg
-
Administration:i.v.
-
Result:Improved canine brief pain inventory (CBPI), pain severity (PS) and pain interference (PI) scores.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG1-kappa
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 1632282-27-9
-
SMILES
[Ranevetmab]
-
Synonyms
NV-01
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Ranevetmab Related Classifications
HY-P99820 Related Classifications
Powered by Bioz